{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:01:11Z","timestamp":1793797271712,"version":"4.6.1"},"reference-count":529,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pharmr.2026.100134","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:51:02Z","timestamp":1775026262000},"page":"100134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunomodulatory and anticancer effects of phytochemicals: A comprehensive analysis"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-6291","authenticated-orcid":false,"given":"Mohamed A.","family":"Eltokhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-8885","authenticated-orcid":false,"given":"Marina","family":"Curcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2325-2246","authenticated-orcid":false,"given":"Shadan","family":"Modaresahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-3263","authenticated-orcid":false,"given":"Ninh M.","family":"La-Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-0438","authenticated-orcid":false,"given":"Sanjay K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032476","article-title":"Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways","volume":"7","author":"Shanmugam","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14715\/cmb\/2018.64.8.5","article-title":"Bioactive compounds and health benefits of edible Rumex species-A review","volume":"64","author":"Prakash Mishra","year":"2018","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100134_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","article-title":"The therapeutic potential of curcumin: a review of clinical trials","volume":"163","author":"Salehi","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100134_bib6","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.lfs.2005.12.014","article-title":"Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program\u2014a public health program","volume":"78","author":"Srinivasan","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib7","article-title":"Impact of extraction techniques on phytochemical composition and bioactivity of natural product mixtures","volume":"16","author":"Sun","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1872211313666190503112040","article-title":"Nutraceuticals\u2019 novel formulations: the good, the bad, the unknown and patents involved","volume":"13","author":"Helal","year":"2019","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.pharmr.2026.100134_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.micpath.2018.08.034","article-title":"Role of secondary metabolites in plant defense against pathogens","volume":"124","author":"Zaynab","year":"2018","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib10","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1080\/10408398.2014.982243","article-title":"Potential benefits of edible berries in the management of aerodigestive and gastrointestinal tract cancers: preclinical and clinical evidence","volume":"56","author":"Bishayee","year":"2016","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib11","first-page":"1191","article-title":"Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance","volume":"12","author":"Bishayee","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib12","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.21873\/anticanres.13720","article-title":"Chemoprevention of prostate cancer by natural agents: evidence from molecular and epidemiological studies","volume":"39","author":"Mokbel","year":"2019","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/molecules22030395","article-title":"Cancer chemoprevention by phytochemicals: nature\u2019s healing touch","volume":"22","author":"Zubair","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/107555303321223035","article-title":"Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)","volume":"9","author":"Chainani-Wu","year":"2003","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib15","series-title":"Bioactive Compounds of Medicinal Plants: Properties and Potential for Human Health","author":"Goyal","year":"2018"},{"key":"10.1016\/j.pharmr.2026.100134_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.783832","article-title":"Essential oil disinfectant efficacy against SARS-CoV-2 microbial surrogates","volume":"9","author":"Bailey","year":"2021","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J Nat Prod"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/biom11081107","article-title":"Phytochemicals in cancer immune checkpoint inhibitor therapy","volume":"11","author":"Lee","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3184\/003685017X14876775256129","article-title":"A hundred years in the elucidation of the structures of natural products","volume":"100","author":"Hanson","year":"2017","journal-title":"Sci Prog"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100134_bib20","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.7150\/jca.34374","article-title":"The power of phytochemicals combination in cancer chemoprevention","volume":"11","author":"Rizeq","year":"2020","journal-title":"J Cancer"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415765","article-title":"Phytochemicals as chemo-preventive agents and signaling molecule modulators: current role in cancer therapeutics and inflammation","volume":"23","author":"Ahmed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100134_bib22","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2174\/0109298673274796240116105555","article-title":"Modulatory role of phytochemicals\/natural products in cancer immunotherapy","volume":"31","author":"Vijayan","year":"2024","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/10408398.2018.1537237","article-title":"The immunomodulatory potential of natural compounds in tumor-bearing mice and humans","volume":"59","author":"Pan","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/app122010548","article-title":"The use of phytochemicals to improve the efficacy of immune checkpoint inhibitors: opportunities and challenges","volume":"12","author":"Guven","year":"2022","journal-title":"Appl Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ptr.8082","article-title":"Phytochemicals in regulating PD-1\/PD-L1 and immune checkpoint blockade therapy","volume":"38","author":"Zhang","year":"2024","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410300","article-title":"Natural products as promising modulators of breast cancer immunotherapy","volume":"15","author":"Alqathama","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1408377","article-title":"Natural plant-derived polysaccharides targeting macrophage polarization: a promising strategy for cancer immunotherapy","volume":"15","author":"Wei","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1481850","article-title":"Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment","volume":"15","author":"Song","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070367","article-title":"Natural biomolecules and derivatives as anticancer immunomodulatory agents","volume":"13","author":"Bernitsa","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib30","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/ph16121652","article-title":"Phytochemicals as immunomodulatory molecules in cancer therapeutics","volume":"16","author":"Paudel","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.canlet.2016.06.023","article-title":"Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells","volume":"380","author":"Coombs","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmr.2026.100134_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155608","article-title":"Targeting CD8+ T cells with natural products for tumor therapy: revealing insights into the mechanisms","volume":"129","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12032-023-02019-4","article-title":"CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies","volume":"40","author":"Faeq","year":"2023","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.semcancer.2020.12.001","article-title":"Pivotal role of PD-1\/PD-L1 immune checkpoints in immune escape and cancer progression: their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals","volume":"86","author":"Lee","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1A","key":"10.1016\/j.pharmr.2026.100134_bib38","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100134_bib39","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.3390\/cancers14225482","article-title":"Research trend and detailed insights into the molecular mechanisms of food bioactive compounds against cancer: a comprehensive review with special emphasis on probiotics","volume":"14","author":"Agrawal","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2012.10.020","article-title":"Pancreatic cancer chemoprevention by phytochemicals","volume":"334","author":"Boreddy","year":"2013","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/excr.2001.5381","article-title":"Curcumin induces apoptosis in human melanoma cells through a Fas receptor\/caspase-8 pathway independent of p53","volume":"271","author":"Bush","year":"2001","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib42","first-page":"2125","article-title":"Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways","volume":"30","author":"WU","year":"2010","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-2187-2-10","article-title":"Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis","volume":"2","author":"Shankar","year":"2007","journal-title":"J Mol Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/carcin\/23.1.143","article-title":"Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xL","volume":"23","author":"Anto","year":"2002","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1631\/jzus.B0820238","article-title":"Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells","volume":"10","author":"Wang","year":"2009","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib46","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjc.6605039","article-title":"Activation of ATM\/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells","volume":"100","author":"Sahu","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ptr.7305","article-title":"Curcumin and its derivatives in cancer therapy: potentiating antitumor activity of cisplatin and reducing side effects","volume":"36","author":"Abadi","year":"2022","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/biof.1776","article-title":"Targeting of the tumor microenvironment by curcumin","volume":"47","author":"Fu","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmr.2026.100134_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111888","article-title":"Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential","volume":"141","author":"Fu","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/molecules25030689","article-title":"Curcumin delivery mediated by bio-based nanoparticles: a review","volume":"25","author":"Moballegh Nasery","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100134_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120984","article-title":"Curcumin in the treatment of urological cancers: therapeutic targets, challenges and prospects","volume":"309","author":"Hashemi","year":"2022","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/cancers11030357","article-title":"Novel curcumin inspired bis-chalcone promotes endoplasmic reticulum stress and glioblastoma neurosphere cell death","volume":"11","author":"Sansalone","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.intimp.2012.06.016","article-title":"Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro","volume":"14","author":"Zhao","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib55","first-page":"2139","article-title":"Curcumin decreases epithelial-mesenchymal transition by a Pirin-dependent mechanism in cervical cancer cells","volume":"42","author":"Aedo-Aguilera","year":"2019","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib56","first-page":"2132","article-title":"Curcumin enhances cisplatin sensitivity by suppressing NADPH oxidase 5 expression in human epithelial cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.pharmr.2026.100134_bib57","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419861600","article-title":"Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1\/VEGF-D signaling","volume":"33","author":"Da","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib58","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","article-title":"Apigenin: a promising molecule for cancer prevention","volume":"27","author":"Shukla","year":"2010","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/biof.1710","article-title":"Luteolin, inflammation and cancer: special emphasis on gut microbiota","volume":"47","author":"Franza","year":"2021","journal-title":"Biofactors"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib60","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ptr.7044","article-title":"Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated","volume":"35","author":"Ganai","year":"2021","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12935-020-01634-9","article-title":"Autophagy regulation using luteolin: new insight into its anti-tumor activity","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.pharmr.2026.100134_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153437","article-title":"Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway","volume":"81","author":"Wu","year":"2021","journal-title":"Phytomedicine"},{"issue":"6371","key":"10.1016\/j.pharmr.2026.100134_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/antiox8080299","article-title":"Antioxidant and potentially anti-inflammatory activity of anthocyanin fractions from pomace obtained from enzymatically treated raspberries","volume":"8","author":"Szymanowska","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47903-0","article-title":"Anthocyanins, delphinidin-3-O-glucoside and cyanidin-3-O-glucoside, inhibit immune checkpoints in human colorectal cancer cells in vitro and in silico","volume":"9","author":"Mazewski","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100134_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semcancer.2020.05.011","article-title":"Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement","volume":"80","author":"Aggarwal","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib67","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3390\/molecules23082071","article-title":"Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth","volume":"23","author":"Rawangkan","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18632\/aging.102646","article-title":"Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity","volume":"12","author":"Verdura","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.pharmr.2026.100134_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-019-0247-4","article-title":"Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells","volume":"14","author":"Zhang","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.pharmr.2026.100134_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105824","article-title":"Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells","volume":"75","author":"Ke","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/molecules25020252","article-title":"Inhibitory effect of hesperidin on the expression of programmed death ligand (PD-L1) in breast cancer","volume":"25","author":"Kongtawelert","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib72","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/eji.201948225","article-title":"Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice","volume":"49","author":"Hao","year":"2019","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib73","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/eji.202048905","article-title":"Icaritin inhibits PD-L1 expression by Targeting Protein I\u03baB kinase \u03b1","volume":"51","author":"Mo","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108479","article-title":"Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism","volume":"690","author":"Sellam","year":"2020","journal-title":"Arch Biochem Biophys"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib75","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1080\/15384101.2016.1245249","article-title":"STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer","volume":"15","author":"Cuy\u00e0s","year":"2016","journal-title":"Cell Cycle"},{"issue":"B","key":"10.1016\/j.pharmr.2026.100134_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.fct.2018.04.028","article-title":"Silibinin is a direct inhibitor of STAT3","volume":"116","author":"Verdura","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmr.2026.100134_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153758","article-title":"The effect of curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer","volume":"92","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib78","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/ijms23073966","article-title":"In silico and in vitro screening of 50 curcumin compounds as EGFR and NF-\u03baB inhibitors","volume":"23","author":"Saeed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib79","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/pharmaceutics15051519","article-title":"Curcumin enhances the abscopal effect in mice with colorectal cancer by acting as an immunomodulator","volume":"15","author":"Shih","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib80","article-title":"The efficacy of curcumin in reducing immunosuppressive states of peripheral blood mononuclear cells extracted from oral squamous cell carcinoma patients: an in vitro study","volume":"17","author":"Dash","year":"2025","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib81","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib82","first-page":"233","article-title":"Apigenin and cancer chemoprevention: progress, potential and promise (review)","volume":"30","author":"Patel","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmr.2026.100134_bib83","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231161174","article-title":"Immunopotentiation effects of apigenin on NK cell proliferation and killing pancreatic cancer cells","volume":"37","author":"Feng","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116251","article-title":"Effects of apigenin on gastric cancer cells","volume":"172","author":"Pratas","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2026.100134_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101920","article-title":"Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma","volume":"43","author":"Singh","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.pharmr.2026.100134_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155611","article-title":"Effect of luteolin on glioblastoma\u2019s immune microenvironment and tumor growth suppression","volume":"130","author":"Zong","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmr.2026.100134_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111057","article-title":"Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-\u03b3-modulated microenvironment in vitro, in vivo, and in clinical patients","volume":"133","author":"Kuo","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11060-019-03193-0","article-title":"Triptolide reverses helper T cell inhibition and down-regulates IFN-\u03b3 induced PD-L1 expression in glioma cell lines","volume":"143","author":"Zhang","year":"2019","journal-title":"J Neurooncol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib89","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib90","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1039\/D0FO00255K","article-title":"Bilberry anthocyanin extracts enhance anti-PD-L1 efficiency by modulating gut microbiota","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib91","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1096\/fj.201900945R","article-title":"Cyanidin-3-glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth","volume":"34","author":"Baster","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094298","article-title":"Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation","volume":"9","author":"Fofaria","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib94","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00262-023-03487-3","article-title":"Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma","volume":"72","author":"Lasso","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib95","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/aps.2011.209","article-title":"Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model","volume":"33","author":"Lai","year":"2012","journal-title":"Acta Pharmacol Sin"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib96","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3390\/app9204270","article-title":"Piperine-a major principle of black pepper: a review of its bioactivity and studies","volume":"9","author":"Stojanovi\u0107-Radi\u0107","year":"2019","journal-title":"Appl Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib97","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/cancers14112644","article-title":"Unveiling the molecular mechanisms driving the capsaicin-induced immunomodulatory effects on PD-L1 expression in bladder and renal cancer cell lines","volume":"14","author":"Morelli","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib98","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.178.5.3260","article-title":"Immunotherapy of tumors with neuroimmune ligand capsaicin","volume":"178","author":"Beltran","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2017.03.025","article-title":"The use of flow cytometry to examine calcium signalling by TRPV1 in mixed cell populations","volume":"527","author":"Assas","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmr.2026.100134_bib100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","article-title":"Triptolide: medicinal chemistry, chemical biology and clinical progress","volume":"176","author":"Hou","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100134_bib101","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phytochem.2019.02.001","article-title":"Sesquiterpene lactones and their precursors as chemosystematic markers in the tribe Cichorieae of the Asteraceae revisited: an update (2008\u20132017)","volume":"163","author":"Shulha","year":"2019","journal-title":"Phytochemistry"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146832","article-title":"Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation","volume":"131","author":"Xu","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.pharmr.2026.100134_bib103","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/247685","article-title":"Sesquiterpene lactones from Artemisia genus: biological activities and methods of analysis","volume":"2015","author":"Ivanescu","year":"2015","journal-title":"J Anal Methods Chem"},{"key":"10.1016\/j.pharmr.2026.100134_bib104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2019.01.041","article-title":"Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo","volume":"70","author":"Cao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102351","article-title":"Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma","volume":"54","author":"Xu","year":"2022","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/cancers15030653","article-title":"The sesquiterpene lactone-rich fraction of Inula helenium L. enhances the antitumor effect of anti-PD-1 antibody in colorectal cancer: integrative phytochemical, transcriptomic, and experimental analyses","volume":"15","author":"Chun","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib107","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/ijms22020608","article-title":"Artesunate switches monocytes to an inflammatory phenotype with the ability to kill leukemic cells","volume":"22","author":"Mancuso","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (Artic M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmr.2026.100134_bib109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","article-title":"Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (Artic M33\/2)","volume":"54","author":"von Hagens","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmr.2026.100134_bib110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12935-019-0789-y","article-title":"Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells","volume":"19","author":"Jiang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.pharmr.2026.100134_bib111","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopha.2017.09.129","article-title":"Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune","volume":"96","author":"Jiang","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib112","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1039\/C9FO02166C","article-title":"Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-\u03baB pathway in lung adenocarcinoma","volume":"11","author":"Hu","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.pharmr.2026.100134_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104727","article-title":"Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1\u03b1 and STAT3 in human colon cancer cells","volume":"155","author":"Wang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib114","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.phrs.2018.08.004","article-title":"Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1\u03b1 and STAT3","volume":"135","author":"Xing","year":"2018","journal-title":"Pharmacol Res"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100134_bib115","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.3390\/ijms21218035","article-title":"Cannabinoids inhibited pancreatic cancer via P-21 activated kinase 1 mediated pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151538","article-title":"\u03b2-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT","volume":"122","author":"Liang","year":"2020","journal-title":"Acta Histochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib117","article-title":"Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMC Oncol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib118","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Investig New Drugs"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib119","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/pharmaceutics14020395","article-title":"Artemisinin-type drugs in tumor cell death: mechanisms, combination treatment with biologics and nanoparticle delivery","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","article-title":"Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin","volume":"91","author":"Lai","year":"1995","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib121","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","article-title":"Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells","volume":"70","author":"Singh","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.828856","article-title":"Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge?","volume":"12","author":"Ma","year":"2021","journal-title":"Front Pharmacol"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100134_bib123","doi-asserted-by":"crossref","first-page":"28480","DOI":"10.1021\/acsnano.4c06369","article-title":"Immune implications of cholesterol-containing lipid nanoparticles","volume":"18","author":"Back","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib124","article-title":"Targeting inhibition of accumulation and function of myeloid-derived suppressor cells by artemisinin via PI3K\/AKT, mTOR, and MAPK pathways enhances anti-PD-L1 immunotherapy in melanoma and liver tumors","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","article-title":"MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy","volume":"32","author":"Ibrahim","year":"2025","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBiomedicine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.62347\/XNVR3799","article-title":"Triptolide induces immunogenic cell death in cervical cancer cells via ER stress and redox modulation","volume":"15","author":"Zheng","year":"2025","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/molecules26010085","article-title":"Health benefits and chemical composition of matcha green tea: a review","volume":"26","author":"Kochman","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11010-022-04550-w","article-title":"Epigallocatechin-3-gallate inhibits the formation of neutrophil extracellular traps and suppresses the migration and invasion of colon cancer cells by regulating STAT3\/CXCL8 pathway","volume":"478","author":"Zhang","year":"2023","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib131","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/nu12041042","article-title":"Green tea polyphenol EGCG attenuates MDSCs-mediated immunosuppression through canonical and non-canonical pathways in a 4T1 murine breast cancer model","volume":"12","author":"Xu","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib132","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cam4.186","article-title":"Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer","volume":"3","author":"Forghani","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib133","article-title":"Immunomodulation of nutritional formula containing epigallocatechin-3-gallate, ginseng extract, and polydextrose on inflammation and macrophage polarization","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib134","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1002\/fsn3.3427","article-title":"Epigallocatechin gallate (EGCG) inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells via modulating nuclear factor kappa-light-chain enhancer of activated B cells (NF-\u03baB) signaling pathway","volume":"11","author":"Hossen","year":"2023","journal-title":"Food Sci Nutr"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/foods9030340","article-title":"Health benefits and molecular mechanisms of resveratrol: a narrative review","volume":"9","author":"Meng","year":"2020","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib136","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/fft2.375","article-title":"Certainty and uncertainty in the biological activities of resveratrol","volume":"5","author":"Drago","year":"2024","journal-title":"Food Front"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib137","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/fsn3.3933","article-title":"Exploring the multimodal health-promoting properties of resveratrol: a comprehensive review","volume":"12","author":"Faisal","year":"2024","journal-title":"Food Sci Nutr"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib138","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.3390\/ijms22095006","article-title":"Resveratrol protects cardiac tissue in experimental malignant hypertension due to antioxidant, anti-inflammatory, and anti-apoptotic properties","volume":"22","author":"Gruji\u0107-Milanovi\u0107","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib139","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.3390\/nu15204486","article-title":"The pharmacological properties of red grape polyphenol resveratrol: clinical trials and obstacles in drug development","volume":"15","author":"Farhan","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5152\/eurasianjmed.2024.24392","article-title":"Potential using of resveratrol and its derivatives in medicine","volume":"56","author":"Ko\u00e7","year":"2024","journal-title":"Eurasian J Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib141","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijms18122589","article-title":"The role of resveratrol in cancer therapy","volume":"18","author":"Ko","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05870.x","article-title":"Resveratrol and cellular mechanisms of cancer prevention","volume":"1215","author":"Shukla","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib143","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.taap.2006.12.025","article-title":"Resveratrol: a review of preclinical studies for human cancer prevention","volume":"224","author":"Athar","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"npj Precis Oncol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib145","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1530\/ERC-13-0171","article-title":"Resveratrol and cancer: focus on in vivo evidence","volume":"21","author":"Carter","year":"2014","journal-title":"Endocr-Relat Cancer"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib146","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12672-025-02471-w","article-title":"Modulation of the PI3K\/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity","volume":"16","author":"Hedayati","year":"2025","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib147","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib148","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3892\/mmr.2015.4695","article-title":"Resveratrol induces apoptosis through modulation of the Akt\/FoxO3a\/Bim pathway in HepG2 cells","volume":"13","author":"Liu","year":"2016","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib149","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","article-title":"Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-\u03baB\u2013regulated antiapoptotic and cell survival gene products in human multiple myeloma cells","volume":"109","author":"Bhardwaj","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1535-7163.MCT-05-0268","article-title":"Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein","volume":"5","author":"Kotha","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib151","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.3892\/mmr.2017.7612","article-title":"Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K\/AKT signaling in hepatocellular carcinoma cells","volume":"16","author":"Chai","year":"2017","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib152","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/cancers13020188","article-title":"Resveratrol\u2019s anti-cancer effects through the modulation of tumor glucose metabolism","volume":"13","author":"Brockmueller","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib153","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/cancers15102758","article-title":"Inhibitory potential of resveratrol in cancer metastasis: from biology to therapy","volume":"15","author":"Song","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib154","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/medicines6010024","article-title":"Differential methylation and acetylation as the epigenetic basis of resveratrol\u2019s anticancer activity","volume":"6","author":"Farhan","year":"2019","journal-title":"Medicines"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100134_bib155","doi-asserted-by":"crossref","first-page":"24718","DOI":"10.18632\/oncotarget.25339","article-title":"Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer","volume":"9","author":"Otsuka","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2026.100134_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1326682","article-title":"Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases","volume":"14","author":"Tian","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2018.10.432","article-title":"Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation","volume":"130","author":"Pinheiro","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib158","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3390\/antiox12122056","article-title":"Anti-cancer properties of resveratrol: a focus on its impact on mitochondrial functions","volume":"12","author":"Kursvietiene","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib159","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/targets2040018","article-title":"The role of resveratrol in cancer management: from monotherapy to combination regimens","volume":"2","author":"Ribeiro","year":"2024","journal-title":"Targets"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/medicina61060981","article-title":"From nature to nanomedicine: enhancing the antitumor efficacy of Rhein, curcumin, and resveratrol","volume":"61","author":"Trofin","year":"2025","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib161","first-page":"630","article-title":"Resveratrol suppresses colon cancer growth by targeting the AKT\/STAT3 signaling pathway","volume":"43","author":"Li","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib162","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnut.2016.00008","article-title":"Anticancer Molecular Mechanisms of Resveratrol","volume":"3","author":"Varoni","year":"2016","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib163","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jox11010002","article-title":"The effects of resveratrol on prostate cancer through targeting the tumor microenvironment","volume":"11","author":"Silk","year":"2021","journal-title":"J Xenobiot"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib164","first-page":"144","article-title":"Resveratrol in prostate diseases\u2014a short review","volume":"66","author":"Jasi\u0144ski","year":"2013","journal-title":"Cent Eur J Urol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib165","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1167\/iovs.07-1233","article-title":"Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction","volume":"49","author":"Van Ginkel","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib166","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.18632\/aging.103338","article-title":"Resveratrol inhibits the malignant progression of hepatocellular carcinoma via March1-induced regulation of PTEN\/AKT signaling","volume":"12","author":"Dai","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.pharmr.2026.100134_bib167","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cellimm.2016.11.002","article-title":"Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages","volume":"311","author":"Sun","year":"2017","journal-title":"Cell Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib168","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/jn\/131.8.2197","article-title":"Downregulation of the cyclin D1\/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines","volume":"131","author":"Wolter","year":"2001","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib169","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3892\/mmr.2014.3100","article-title":"Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells","volume":"11","author":"Yuan","year":"2015","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib170","first-page":"1466","article-title":"Resveratrol causes WAF-1\/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells","volume":"7","author":"Ahmad","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.467","article-title":"Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer","volume":"5","author":"Hasima","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib172","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12885-018-4504-5","article-title":"Resveratrol induces autophagy-dependent apoptosis in HL-60 cells","volume":"18","author":"Fan","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmr.2026.100134_bib173","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.2147\/OTT.S213043","article-title":"Resveratrol as a natural regulator of autophagy for prevention and treatment of cancer","volume":"12","author":"Tian","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib174","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5114\/aoms\/119022","article-title":"Resveratrol promotes apoptosis and G2\/M cell cycle arrest of fibroblast-like synoviocytes in rheumatoid arthritis through regulation of autophagy and the serine-threonine kinase-p53 axis","volume":"20","author":"Li","year":"2021","journal-title":"Arch Med Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3892\/ijo.2017.3866","article-title":"Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: a key role of AMPK and Akt\/mTOR signaling","volume":"50","author":"Chang","year":"2017","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib176","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.3390\/molecules15107035","article-title":"Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies","volume":"15","author":"Kelkel","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100134_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115346","article-title":"Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR\/Ferroptosis in lung squamous cell carcinoma","volume":"229","author":"Shan","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pharmr.2026.100134_bib178","article-title":"Resveratrol activates CD8+ T cells through IL-18 bystander activation in lung adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib179","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1829346","article-title":"Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.intimp.2007.12.006","article-title":"Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells","volume":"8","author":"Yang","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib181","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6781872","article-title":"The repeated administration of resveratrol has measurable effects on circulating T-cell subsets in humans","volume":"2017","author":"Espinoza","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib182","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/nu11050946","article-title":"Influence of resveratrol on the immune response","volume":"11","author":"Malaguarnera","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib183","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/08830185.2012.665108","article-title":"Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases","volume":"31","author":"\u0160vajger","year":"2012","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib184","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/molecules27020424","article-title":"Resveratrol and immune cells: a link to improve human health","volume":"27","author":"Alesci","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3892\/etm.2012.472","article-title":"Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells","volume":"3","author":"Choi","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib186","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fphar.2015.00079","article-title":"Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue","volume":"6","author":"Zagotta","year":"2015","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib187","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4162\/nrp.2021.15.1.26","article-title":"Effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats","volume":"15","author":"Xiao","year":"2021","journal-title":"Nutr Res Pract"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib188","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1002\/ptr.7189","article-title":"Boosting immune system against cancer by resveratrol","volume":"35","author":"Chen","year":"2021","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib189","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3390\/molecules26051343","article-title":"Recent advancements on immunomodulatory mechanisms of resveratrol in tumor microenvironment","volume":"26","author":"Chhabra","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100134_bib190","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2018.01255","article-title":"Is resveratrol a cancer immunomodulatory molecule?","volume":"9","author":"Trung","year":"2018","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib191","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/biomedicines8080261","article-title":"Resveratrol modulates transforming growth factor-beta (TGF-\u03b2) signaling pathway for disease therapy: a new insight into its pharmacological activities","volume":"8","author":"Ashrafizadeh","year":"2020","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib192","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0006-2952(01)00775-4","article-title":"Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production","volume":"62","author":"Gao","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib193","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1476-5381.2012.02063.x","article-title":"Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury","volume":"167","author":"Rieder","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.528400","article-title":"Resveratrol modulates the inflammatory profile of immune responses and circulating endothelial cells","volume":"11","author":"Khalil","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib195","article-title":"The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib196","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00125-011-2064-1","article-title":"Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes","volume":"54","author":"Lee","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib197","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/ard.2011.149831","article-title":"Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function","volume":"71","author":"Xuzhu","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib198","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2567.2009.03205.x","article-title":"Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation","volume":"129","author":"\u0160vajger","year":"2010","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib199","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.intimp.2011.07.019","article-title":"Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy","volume":"11","author":"Soto","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1450898","article-title":"Resveratrol promotes cholesterol efflux from dendritic cells and controls costimulation and T-cell activation in high-fat and lipopolysaccharide-driven atherosclerotic mice","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib201","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcp.22043","article-title":"Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways","volume":"223","author":"Lu","year":"2010","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000510315","article-title":"In vivo anti-cancer effects of resveratrol mediated by NK cell activation","volume":"13","author":"Lee","year":"2021","journal-title":"J Innate Immun"},{"key":"10.1016\/j.pharmr.2026.100134_bib203","article-title":"Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1\/JNK\/c-Jun signaling","volume":"16","author":"Ding","year":"2025","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib204","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/ijms20040925","article-title":"Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer","volume":"20","author":"Han","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1516609","article-title":"Resveratrol-driven macrophage polarization: unveiling mechanisms and therapeutic potential","volume":"15","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib206","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12013-015-0513-z","article-title":"Modification of antitumor immunity and tumor microenvironment by resveratrol in mouse renal tumor model","volume":"72","author":"Chen","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib207","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/cancers11121828","article-title":"Synergy of ginkgetin and resveratrol in suppressing VEGF-induced angiogenesis: a therapy in treating colorectal cancer","volume":"11","author":"Hu","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib208","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10456-010-9187-8","article-title":"Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture","volume":"13","author":"Trapp","year":"2010","journal-title":"Angiogenesis"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100134_bib209","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.3390\/molecules25184282","article-title":"Resveratrol and tumor microenvironment: mechanistic basis and therapeutic targets","volume":"25","author":"Talib","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219317","article-title":"Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100134_bib211","article-title":"Resveratrol and its analogs: potent agents to reverse epithelial-to-mesenchymal transition in tumors","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib212","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1111\/bph.14842","article-title":"Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways","volume":"176","author":"Zhang","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib213","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopha.2012.10.008","article-title":"Resveratrol affects the cross talk between immune and colon cancer cells","volume":"67","author":"Bergman","year":"2013","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib214","first-page":"1579","article-title":"Resveratrol inhibits the growth of gastric cancer via the Wnt\/\u03b2-catenin pathway","volume":"16","author":"Dai","year":"2018","journal-title":"Oncol Lett"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib215","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1111\/cas.15576","article-title":"Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map","volume":"113","author":"Wada","year":"2022","journal-title":"Cancer Sci"},{"issue":"501","key":"10.1016\/j.pharmr.2026.100134_bib216","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal3024","article-title":"Resveratrol stimulates the metabolic reprogramming of human CD4+ T cells to enhance effector function","volume":"10","author":"Craveiro","year":"2017","journal-title":"Sci Signal"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib217","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/carcin\/bgi349","article-title":"Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-\u03baB in mouse skin by blocking I\u03baB kinase activity","volume":"27","author":"Kundu","year":"2006","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib218","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.surg.2015.07.012","article-title":"Resveratrol decreases nitric oxide production by hepatocytes during inflammation","volume":"158","author":"Kimbrough","year":"2015","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib219","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-2952(02)01296-0","article-title":"The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle","volume":"64","author":"Pozo-Guisado","year":"2002","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib220","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/molecules24061131","article-title":"RETRACTED: resveratrol inhibits the migration and metastasis of MDA-MB-231 human breast cancer by reversing TGF-\u03b21-induced epithelial-mesenchymal transition","volume":"24","author":"Sun","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib221","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/ijms25010232","article-title":"The combination of bioavailable concentrations of curcumin and resveratrol shapes Immune responses while retaining the ability to Reduce Cancer Cell Survival","volume":"25","author":"Focaccetti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib222","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1390907","article-title":"Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100134_bib223","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrrev.2007.08.004","article-title":"Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?","volume":"658","author":"Saiko","year":"2008","journal-title":"Mutat Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib224","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejcb.2017.08.002","article-title":"Resveratrol promotes human embryonic stem cells self-renewal by targeting SIRT1-ERK signaling pathway","volume":"96","author":"Safaeinejad","year":"2017","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib225","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2014.11.004","article-title":"Resveratrol and cancer: challenges for clinical translation","volume":"1852","author":"Singh","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib226","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/1078-0432.CCR-10-1486","article-title":"Resveratrol: challenges in translation to the clinic\u2014a critical discussion","volume":"16","author":"Subramanian","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib227","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.bcp.2009.03.002","article-title":"Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice","volume":"77","author":"Sun","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100134_bib228","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.7150\/thno.24821","article-title":"Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma","volume":"8","author":"Hou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmr.2026.100134_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.160987","article-title":"Synergistic induction of immunogenic cell death by icaritin, JQ1, and doxorubicin to enhance immunotherapy in hepatocellular carcinoma","volume":"508","author":"Pan","year":"2025","journal-title":"Chem Eng J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib230","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acsami.4c13433","article-title":"Mitochondria-targeted icaritin nanoparticles induce immunogenic cell death in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib231","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10735-015-9621-8","article-title":"Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-\u03baB and MAPK signal pathways","volume":"46","author":"Wang","year":"2015","journal-title":"J Mol Histol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib232","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1159\/000470815","article-title":"Baicalein, a natural anti-cancer compound, alters microRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells","volume":"41","author":"Bie","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib233","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lfs.2005.04.072","article-title":"Absorption and enterohepatic circulation of baicalin in rats","volume":"78","author":"Xing","year":"2005","journal-title":"Life Sci"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100134_bib234","doi-asserted-by":"crossref","first-page":"20089","DOI":"10.18632\/oncotarget.24015","article-title":"Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence","volume":"9","author":"Dou","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2026.100134_bib235","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.2147\/DDDT.S181939","article-title":"Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro","volume":"12","author":"Yan","year":"2018","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.pharmr.2026.100134_bib236","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.743837","article-title":"Baicalein potentiated M1 macrophage polarization in cancer through targeting PI3K\u03b3\/NF-\u03baB signaling","volume":"12","author":"He","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib237","article-title":"Multifunctional baicalin nanoparticles inhibit tumor cell growth and activate RAW264. 7 macrophages","volume":"97","author":"Liu","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib238","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/fsn3.4010","article-title":"Silymarin: unveiling its pharmacological spectrum and therapeutic potential in liver diseases\u2014a comprehensive narrative review","volume":"12","author":"Jaffar","year":"2024","journal-title":"Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib239","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib240","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jnci\/89.8.556","article-title":"Protective effects of silymarin against photocarcinogenesis in a mouse skin model","volume":"89","author":"Katiyar","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib241","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1535-7163.MCT-06-0095","article-title":"Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice","volume":"5","author":"Meeran","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib242","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.intimp.2013.04.016","article-title":"Immunomodulatory effects of silymarin in patients with \u03b2-thalassemia major","volume":"16","author":"Gharagozloo","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib243","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.canlet.2008.03.053","article-title":"Multitargeted therapy of cancer by silymarin","volume":"269","author":"Ramasamy","year":"2008","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib244","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171139","article-title":"Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells","volume":"12","author":"Lovelace","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100134_bib245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.intimp.2017.06.030","article-title":"Silymarin impacts on immune system as an immunomodulator: one key for many locks","volume":"50","author":"Esmaeil","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib246","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X211068826","article-title":"Role of silymarin in cancer treatment: facts, hypotheses, and questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J Evid-Based Integr Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib247","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/molecules25092009","article-title":"Silymarin and cancer: a dual strategy in both in chemoprevention and chemosensitivity","volume":"25","author":"Delmas","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111109","article-title":"The clinical anti-inflammatory effects and underlying mechanisms of silymarin","volume":"27","author":"Zhao","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib249","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/antiox13010098","article-title":"Silymarin and inflammation: food for thoughts","volume":"13","author":"Surai","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmr.2026.100134_bib250","series-title":"Role of Nutraceuticals in Cancer Chemosensitization","first-page":"199","article-title":"Anticancer attributes of silibinin: chemo-and radiosensitization of cancer","author":"Dheeraj","year":"2018"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib251","first-page":"81","article-title":"Silibinin inhibits TGF-\u03b2-induced MMP-2 and MMP-9 through Smad Signaling pathway in colorectal cancer HT-29 cells","volume":"12","author":"Zare","year":"2020","journal-title":"Basic Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib252","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12672-025-01800-3","article-title":"Silymarin: a promising modulator of apoptosis and survival signaling in cancer","volume":"16","author":"Sharma","year":"2025","journal-title":"Discov Oncol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib253","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1007\/s13277-016-5000-7","article-title":"Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-\u03b22 expression","volume":"37","author":"Kim","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pharmr.2026.100134_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105384","article-title":"Silymarin in cancer therapy: mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations","volume":"100","author":"Wang","year":"2023","journal-title":"J Funct Foods"},{"key":"10.1016\/j.pharmr.2026.100134_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105502","article-title":"Critical review of therapeutic potential of silymarin in cancer: a bioactive polyphenolic flavonoid","volume":"104","author":"Koushki","year":"2023","journal-title":"J Funct Foods"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib256","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/RPS.RPS_204_24","article-title":"Dietary silymarin supplementation enhances chemotherapy efficacy of capecitabine and irinotecan and mitigates hepatotoxicity in a mouse model of colon cancer","volume":"20","author":"Hassani","year":"2025","journal-title":"Res Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib257","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12935-023-02936-4","article-title":"A systematic review of the protective effects of silymarin\/silibinin against doxorubicin-induced cardiotoxicity","volume":"23","author":"Singh","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.pharmr.2026.100134_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107715","article-title":"Significant immunomodulatory and hepatoprotective impacts of silymarin in MS patients: a double-blind placebo-controlled clinical trial","volume":"97","author":"Abbasirad","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib259","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1007\/s12035-025-04903-8","article-title":"Evaluating the protective effects of silymarin along with a cholesterol-supplemented diet against demyelination in an EAE mouse model of multiple sclerosis: lipidomic and inflammatory aspects","volume":"62","author":"Mosaddeghi","year":"2025","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib260","article-title":"Silymarin as an antioxidant therapy in chronic liver diseases: a comprehensive review","volume":"16","author":"Dhande","year":"2024","journal-title":"Cureus"},{"issue":"49","key":"10.1016\/j.pharmr.2026.100134_bib261","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009061","article-title":"The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: a meta-analysis (PRISMA) of randomized control trials","volume":"96","author":"Zhong","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib262","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","article-title":"Immunoregulatory effects of silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-\u00df1b-treated MS patients","volume":"42","author":"Navabi","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmr.2026.100134_bib263","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.659678","article-title":"Silybin alleviates experimental autoimmune encephalomyelitis by suppressing dendritic cell activation and Th17 cell differentiation","volume":"12","author":"Yang","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib264","doi-asserted-by":"crossref","DOI":"10.1155\/ijcp\/3985207","article-title":"The impact of silymarin on inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials","volume":"2025","author":"Vajdi","year":"2025","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.54319\/jjbs\/170114","article-title":"Synergistic antineoplastic and immunomodulatory effects of hesperidin in Ehrlich ascites carcinoma tumor model treated with cisplatin","volume":"17","author":"Abd El Latif","year":"2024","journal-title":"Jordan J Biol Sci"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100134_bib266","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3390\/molecules28135152","article-title":"Hesperidin, a bioflavonoid in cancer therapy: a review for a mechanism of action through the modulation of cell signaling pathways","volume":"28","author":"Rahmani","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib267","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/life13040937","article-title":"Current update on role of hesperidin in inflammatory lung diseases: chemistry, pharmacology, and drug delivery approaches","volume":"13","author":"Hosawi","year":"2023","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib268","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3390\/medicina60060892","article-title":"Hesperidin, a potential antiviral agent against SARS-CoV-2: the influence of citrus consumption on COVID-19 incidence and severity in China","volume":"60","author":"Kowalczyk","year":"2024","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib269","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/nu11020324","article-title":"Hesperidin effects on gut microbiota and gut-associated lymphoid tissue in healthy rats","volume":"11","author":"Estruel-Amades","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib270","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/nu9060580","article-title":"Influence of hesperidin on the systemic and intestinal rat immune response","volume":"9","author":"Camps-Bossacoma","year":"2017","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"10.1016\/j.pharmr.2026.100134_bib529","first-page":"S15","article-title":"Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cells","volume":"24","author":"Lee","year":"2010","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib271","article-title":"Hesperidin inhibits oral cancer cell growth via apoptosis and inflammatory signaling-mediated mechanisms: evidence from in vitro and in silico analyses","volume":"16","author":"Jayaraman","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib272","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1535370220903671","article-title":"Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements","volume":"245","author":"Aggarwal","year":"2020","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107562","article-title":"Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: a systematic review of preclinical evidence","volume":"95","author":"Bayat","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib274","doi-asserted-by":"crossref","first-page":"29567","DOI":"10.18535\/jmscr\/v5i10.185","article-title":"Hesperidin and experimentally-induced arthritis in male rats","volume":"5","author":"Sakr","year":"2017","journal-title":"J Med Sci Clin Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib275","first-page":"3721","article-title":"Hesperidin protects against IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes","volume":"16","author":"Fu","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib276","unstructured":"Aja PM, Ogbu CO, AGU PC, et al. Hesperidin Suppresses Complete Freund\u2019s Adjuvant (Cfa)-Induced Rheumatoid Arthritis (Ra) in Rats by Blocking Tnf-\/IL-6\/IL-1 and NF-kB\/Cox-2 Signaling."},{"issue":"5\u20136","key":"10.1016\/j.pharmr.2026.100134_bib277","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000439538","article-title":"Protective effects of simvastatin and hesperidin against complete freund\u2019s adjuvant-induced rheumatoid arthritis in rats","volume":"96","author":"Ahmed","year":"2015","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib278","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/nu12051291","article-title":"Influence of hesperidin on systemic immunity of rats following an intensive training and exhausting exercise","volume":"12","author":"Ruiz-Iglesias","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib279","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5530\/ijpi.14.4.122","article-title":"Exploring the potential of hesperidin and synergistic formulations in breast cancer management: a comprehensive review","volume":"14","author":"Lobo","year":"2024","journal-title":"Int J Pharm Investig"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5606\/ArchRheumatol.2018.6519","article-title":"Bee venom and hesperidin effectively mitigate complete Freund\u2019s adjuvant-induced arthritis via immunomodulation and enhancement of antioxidant defense system","volume":"33","author":"Ahmed","year":"2017","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.pharmr.2026.100134_bib281","doi-asserted-by":"crossref","unstructured":"Miles EA, Calder PC. Effects of citrus fruit juices and their bioactive components on inflammation and immunity: a narrative review. Front Immunol;12:712608. https:\/\/doi.org\/10.3389\/fimmu.2021.712608.","DOI":"10.3389\/fimmu.2021.712608"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib282","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/antiox13111391","article-title":"Human supplementation with AM3, spermidine, and hesperidin enhances immune function, decreases biological age, and improves oxidative\u2013inflammatory state: a randomized controlled trial","volume":"13","author":"F\u00e9lix","year":"2024","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib283","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00394-019-02105-2","article-title":"The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"59","author":"Yari","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.pharmr.2026.100134_bib284","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cbi.2019.04.016","article-title":"The effect of hesperidin supplementation on inflammatory markers in human adults: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"307","author":"Lorzadeh","year":"2019","journal-title":"Chem-Biol Interact"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib285","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6252426","article-title":"Lycopene: a potent antioxidant with multiple health benefits","volume":"2024","author":"Shafe","year":"2024","journal-title":"J Nutr Metab"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib286","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/ijms23041957","article-title":"Lycopene in the prevention of cardiovascular diseases","volume":"23","author":"Przybylska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114428","article-title":"A mechanistic updated overview on lycopene as potential anticancer agent","volume":"161","author":"Ozkan","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2026.100134_bib288","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1364589","article-title":"Physicochemical properties, mechanism of action of lycopene and its application in poultry and ruminant production","volume":"11","author":"Long","year":"2024","journal-title":"Front Vet Sci"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib289","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3390\/ijms20204981","article-title":"Role of phytochemicals in cancer prevention","volume":"20","author":"Ranjan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jnutbio.2012.01.003","article-title":"Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells","volume":"24","author":"Huang","year":"2013","journal-title":"J Nutr Biochem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib291","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/cancers16040714","article-title":"Role of nutraceuticals in counteracting inflammation in in vitro macrophages obtained from childhood cancer survivors","volume":"16","author":"Di Paola","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib292","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5418081","article-title":"Lycopene in feed as antioxidant and immuno-modulator improves broiler Chicken\u2019s performance under heat-stress conditions","volume":"2023","author":"Hidayat","year":"2023","journal-title":"Vet Med Int"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib293","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/10715762.2011.564168","article-title":"Antioxidant and anti-proliferative properties of lycopene","volume":"45","author":"Kelkel","year":"2011","journal-title":"Free Radic Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib294","first-page":"321","article-title":"Current topical strategies for skin-aging and inflammaging treatment: science versus fiction","volume":"71","author":"Eassa","year":"2020","journal-title":"J Cosmet Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib295","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.886988","article-title":"Lycopene in combination with sorafenib additively inhibits tumor metastasis in mice xenografted with lewis lung carcinoma cells","volume":"9","author":"Chan","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.pharmr.2026.100134_bib296","article-title":"Lycopene: multitargeted applications in cancer therapy","volume":"79","author":"Sahin","year":"2017"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib297","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm-146781","article-title":"Lycopene promotes NK cell cytotoxicity towards non-small cell lung carcinoma via regulating NF-\u03baB signaling","volume":"17","author":"Guo","year":"2024","journal-title":"Int J Cancer Manag"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib298","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2567.2004.01945.x","article-title":"Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-\u03baB","volume":"113","author":"Kim","year":"2004","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib299","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042101","article-title":"Lycopene inhibits oxidative stress-mediated inflammatory responses in ethanol\/palmitoleic acid-stimulated pancreatic acinar AR42J cells","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib300","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/jf053033c","article-title":"Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress","volume":"54","author":"Riso","year":"2006","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib301","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0714.2010.00991.x","article-title":"Lycopene: features and potential significance in the oral cancer and precancerous lesions","volume":"40","author":"Lu","year":"2011","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib302","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/1940-6207.CAPR-19-0063","article-title":"Lycopene inhibits smoke-induced chronic obstructive pulmonary disease and lung carcinogenesis by modulating reverse cholesterol transport in ferrets","volume":"12","author":"Mustra Rakic","year":"2019","journal-title":"Cancer Prev Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib303","doi-asserted-by":"crossref","first-page":"691","DOI":"10.52083\/DHFP9578","article-title":"Lycopene alleviates chemotherapy-induced mucositis via enhancing intestinal barrier function and attenuating TLR4\/MyD88\/NF-\u03baB signaling cascade","volume":"28","author":"Elseady","year":"2024","journal-title":"Eur J Anat"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib304","first-page":"1225","article-title":"Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis","volume":"59","author":"Gann","year":"1999","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib305","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/01635580903285023","article-title":"Lycopene effects contributing to prostate health","volume":"61","author":"Wertz","year":"2009","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib306","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00365510802658473","article-title":"Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene","volume":"69","author":"Ali","year":"2009","journal-title":"Scand J Clin Lab Investig"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib307","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jss.2011.09.005","article-title":"Protective effects of lycopene on cerulein-induced experimental acute pancreatitis in rats","volume":"176","author":"\u00d6zkan","year":"2012","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib308","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/antiox11030519","article-title":"Lycopene inhibits IL-6 expression by upregulating NQO1 and HO-1 via activation of Nrf2 in ethanol\/lipopolysaccharide-stimulated pancreatic acinar cells","volume":"11","author":"Lee","year":"2022","journal-title":"Antioxidants"},{"issue":"29","key":"10.1016\/j.pharmr.2026.100134_bib309","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4254\/wjh.v8.i29.1222","article-title":"Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma","volume":"8","author":"Gupta","year":"2016","journal-title":"World J Hepatol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib310","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/01635581.2015.1087040","article-title":"Lycopene enriched tomato extract inhibits hypoxia, angiogenesis, and metastatic markers in early stage N-nitrosodiethylamine induced hepatocellular carcinoma","volume":"67","author":"Bhatia","year":"2015","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib311","doi-asserted-by":"crossref","first-page":"233","DOI":"10.6026\/97320630004233","article-title":"Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity","volume":"4","author":"Upadhyay","year":"2009","journal-title":"Bioinformation"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib312","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mnfr.200700272","article-title":"Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway","volume":"52","author":"Tang","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib313","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lfs.2016.05.021","article-title":"Lycopene ameliorates neuropathic pain by upregulating spinal astrocytic connexin 43 expression","volume":"155","author":"Zhang","year":"2016","journal-title":"Life Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib314","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1349-7006.1997.tb00338.x","article-title":"Differential dose-dependent effects of \u03b1-, \u03b2-carotenes and lycopene on gap-junctional intercellular communication in rat liver in vivo","volume":"88","author":"Krutovskikh","year":"1997","journal-title":"Jpn J Cancer Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib315","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1093\/jn\/132.12.3754","article-title":"Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells","volume":"132","author":"Livny","year":"2002","journal-title":"J Nutr"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib316","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0278-6915(03)00148-0","article-title":"Lycopene oxidation product enhances gap junctional communication","volume":"41","author":"Aust","year":"2003","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmr.2026.100134_bib317","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2019.11.036","article-title":"Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice","volume":"152","author":"Ni","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib318","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00203-024-03971-z","article-title":"Lycopene promoted M2 macrophage polarization via inhibition of NOTCH1-PI3K-mTOR-NF-\u03baB-JMJD3-IRF4 pathway in response to Escherichia coli infection in J744A.1 cells","volume":"206","author":"Zhuang","year":"2024","journal-title":"Arch Microbiol"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100134_bib319","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900602","article-title":"Lycopene alleviates obesity-induced inflammation and insulin resistance by regulating M1\/M2 status of macrophages","volume":"63","author":"Chen","year":"2019","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib320","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/ijc.24689","article-title":"Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats","volume":"126","author":"Wang","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib321","doi-asserted-by":"crossref","first-page":"233","DOI":"10.13181\/mji.v18i4.367","article-title":"The effect of lycopene on the total cytochrome P450, CYP1A2 and CYP2E1","volume":"18","author":"Louisa","year":"2009","journal-title":"Med J Indones"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib322","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.etp.2015.12.004","article-title":"Lycopene protects against atrazine-induced hepatotoxicity through modifications of cytochrome P450 enzyme system in microsomes","volume":"68","author":"Xia","year":"2016","journal-title":"Exp Toxicol Pathol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib323","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers10100368","article-title":"Gap junction intercellular communication positively regulates cisplatin toxicity by inducing DNA damage through bystander signaling","volume":"10","author":"Arora","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib324","first-page":"1377","article-title":"Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines","volume":"34","author":"Gloria","year":"2014","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib325","article-title":"Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition","volume":"2013","author":"Trejo-Sol\u00eds","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100134_bib326","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.3390\/molecules26175333","article-title":"Multifaceted effects of lycopene: a boulevard to the multitarget-based treatment for cancer","volume":"26","author":"Marzocco","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib327","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2867-12-36","article-title":"Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines","volume":"12","author":"Teodoro","year":"2012","journal-title":"Cancer Cell Int"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100134_bib328","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2008.03.001","article-title":"Lycopene inhibits TNF-\u03b1-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion","volume":"586","author":"Hung","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib329","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/nu11040762","article-title":"Lycopene inhibits reactive oxygen species-mediated NF-\u03baB signaling and induces apoptosis in pancreatic cancer cells","volume":"11","author":"Jeong","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18388\/abp.2012_2163","article-title":"Lycopene as a guardian of redox signalling","volume":"59","author":"Palozza","year":"2012","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.pharmr.2026.100134_bib331","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nutres.2018.07.010","article-title":"Lycopene treatment inhibits activation of Jak1\/Stat3 and Wnt\/\u03b2-catenin signaling and attenuates hyperproliferation in gastric epithelial cells","volume":"70","author":"Park","year":"2019","journal-title":"Nutr Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib332","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1940-6207.CAPR-14-0154","article-title":"Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice","volume":"7","author":"Ip","year":"2014","journal-title":"Cancer Prev Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib333","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jcmm.17730","article-title":"Lycopene inhibits endothelial-to-mesenchymal transition of choroidal vascular endothelial cells in laser-induced mouse choroidal neovascularization","volume":"27","author":"Li","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib334","doi-asserted-by":"crossref","first-page":"11304","DOI":"10.1021\/jf202433f","article-title":"Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells","volume":"59","author":"Lin","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/153537020523000303","article-title":"Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells","volume":"230","author":"Hantz","year":"2005","journal-title":"Exp Biol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib336","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/nu12010096","article-title":"The influence of lycopene, [6]-gingerol, and silymarin on the apoptosis on U-118MG glioblastoma cells in vitro model","volume":"12","author":"Czarnik-Kwa\u015bniak","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib337","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biomedicines11020306","article-title":"Role of the endocannabinoid system in metabolic control processes and in the pathogenesis of metabolic syndrome: an update","volume":"11","author":"D\u00f6rnyei","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmr.2026.100134_bib338","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790803","article-title":"Endocannabinoid system as a promising therapeutic target in inflammatory bowel disease - A systematic review","volume":"12","author":"Hryhorowicz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib339","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106025","article-title":"Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract","volume":"175","author":"Lian","year":"2022","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib340","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/jcm14082851","article-title":"The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review","volume":"14","author":"Simankowicz","year":"2025","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib341","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib342","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med Chem"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100134_bib343","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib344","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm0602-547","article-title":"Targeting the endocannabinoid system in cancer therapy: a call for further research","volume":"8","author":"Bifulco","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib345","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/brainsci13030525","article-title":"Cannabinoid receptor agonist WIN55, 212\u20132 attenuates injury in the hippocampus of rats after deep hypothermic circulatory arrest","volume":"13","author":"Yu","year":"2023","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib346","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12031-016-0726-7","article-title":"JWH-133, a selective cannabinoid CB2 receptor agonist, exerts toxic effects on neuroblastoma SH-SY5Y cells","volume":"58","author":"Wojcieszak","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmr.2026.100134_bib347","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109545","article-title":"Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: a relevance for Alzheimer\u2019s disease?","volume":"70","author":"Thompson","year":"2020","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib348","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s43440-021-00308-1","article-title":"Cannabinoids and their derivatives in struggle against melanoma","volume":"73","author":"Marz\u0119da","year":"2021","journal-title":"Pharmacol Rep"},{"issue":"suppl 1","key":"10.1016\/j.pharmr.2026.100134_bib349","first-page":"S163","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib350","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/156800705774322111","article-title":"Cannabinoids","volume":"4","author":"Grotenhermen","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib351","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.pharmr.2026.100134_bib352","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-57369-0_1","article-title":"Constituents of cannabis sativa","volume":"1264","author":"Rock","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib353","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib354","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3181\/00379727-209-43897b","article-title":"\u03949-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila","volume":"209","author":"Klein","year":"1995","journal-title":"Proc Soc Exp Biol Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib355","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-5699(98)01300-0","article-title":"Cannabinoid receptors and immunity","volume":"19","author":"Klein","year":"1998","journal-title":"Immunol Today"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100134_bib356","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"\u03949-tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib357","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"\u0394-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune Response1","volume":"174","author":"McKallip","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib358","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11481-015-9603-3","article-title":"Effects of cannabinoids on T-cell function and resistance to infection","volume":"10","author":"Eisenstein","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100134_bib359","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-5793(95)00746-V","article-title":"Cannabinoids enhance human B-cell growth at low nanomolar concentrations","volume":"369","author":"Derocq","year":"1995","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/jpet.106.108381","article-title":"Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection","volume":"319","author":"Lu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib361","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3390\/ph3082733","article-title":"Dendritic cell regulation by cannabinoid-based drugs","volume":"3","author":"Svensson","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib362","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/eji.201040667","article-title":"Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties","volume":"40","author":"Hegde","year":"2010","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib363","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44446-025-00005-7","article-title":"Cannabidiol as an immune modulator: a comprehensive review","volume":"33","author":"Mujahid","year":"2025","journal-title":"Saudi Pharm J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib364","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1240800","article-title":"The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation","volume":"14","author":"P\u00e9nzes","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib366","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2016.11.006","article-title":"Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation","volume":"312","author":"Dhital","year":"2017","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib367","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/receptors3020007","article-title":"Molecular targets for cannabinoids in natural killer cells: do they modulate the antitumor activity?","volume":"3","author":"Olivas-Aguirre","year":"2024","journal-title":"Receptors"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib368","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib369","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2024.07.008","article-title":"The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells","volume":"174","author":"Wang","year":"2024","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib370","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.105.098541","article-title":"Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana","volume":"317","author":"Zhu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib371","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jpha.2023.04.013","article-title":"Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer","volume":"13","author":"Sun","year":"2023","journal-title":"J Pharm Anal"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib372","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.pharmr.2026.100134_bib373","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1528520","article-title":"CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated head and neck squamous cell carcinoma","volume":"16","author":"Sen","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib374","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/molecules27020491","article-title":"In vitro and clinical evaluation of cannabigerol (CBG) produced via yeast biosynthesis: a Cannabinoid with a broad range of anti-inflammatory and skin health-boosting properties","volume":"27","author":"Perez","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100134_bib375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.982082","article-title":"Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours","volume":"13","author":"Dada","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib376","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117286","article-title":"Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose diet","volume":"178","author":"Sztolsztener","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib377","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/cells14020083","article-title":"Anti-inflammatory effects of cannabigerol in vitro and in vivo are mediated through the JAK\/STAT\/NF\u03baB signaling pathway","volume":"14","author":"Jeong","year":"2025","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib378","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib379","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The pharmacological case for cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib380","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.3390\/molecules29245970","article-title":"The anticancer activity of cannabinol (CBN) and cannabigerol (CBG) on acute myeloid leukemia cells","volume":"29","author":"Kadriya","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib381","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2219164","article-title":"Decreased melanoma CSF-1 secretion by cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression","volume":"12","author":"Wyrobnik","year":"2023","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib382","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/ijms24010855","article-title":"Anti-inflammatory effects of cannabigerol in rheumatoid arthritis synovial fibroblasts and peripheral blood mononuclear cell cultures are partly mediated by TRPA1","volume":"24","author":"Lowin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100134_bib383","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147520","article-title":"Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation","volume":"14","author":"P\u00e9rez-Diego","year":"2023","journal-title":"Front Immunol"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100134_bib384","doi-asserted-by":"crossref","first-page":"21244","DOI":"10.18632\/oncotarget.25052","article-title":"Effects of CB2 and TRPV1 receptors\u2019 stimulation in pediatric acute T-lymphoblastic leukemia","volume":"9","author":"Punzo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2026.100134_bib385","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.702675","article-title":"Pharmacological properties, therapeutic potential and molecular mechanisms of JWH133, a CB2 receptor-selective agonist","volume":"12","author":"Hashiesh","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib386","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1296906","article-title":"Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?","volume":"13","author":"Sarsembayeva","year":"2023","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib387","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3390\/cancers12092447","article-title":"Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome","volume":"12","author":"Bar-Sela","year":"2020","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100134_bib388","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1200\/JCO.23.02596","article-title":"Cannabis and cannabinoids in adults with cancer: ASCO guideline","volume":"42","author":"Braun","year":"2024","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100134_bib389","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3390\/cancers16162909","article-title":"The efficacy of cannabis in oncology patient care and its anti-tumor effects","volume":"16","author":"Shalata","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.pharmr.2026.100134_bib390","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1490621","article-title":"Meta-analysis of medical cannabis outcomes and associations with cancer","volume":"15","author":"Castle","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib391","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/can.2021.0045","article-title":"Cannabis as an anticancer agent: a review of clinical data and assessment of case reports","volume":"7","author":"Guggisberg","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib392","first-page":"83","article-title":"Antitumor effect and pharmacological actions of beta-elemene isolated from the rhizome of Curcuma aromatica","volume":"9","author":"Fu","year":"1984","journal-title":"Zhong Yao Tong Bao"},{"key":"10.1016\/j.pharmr.2026.100134_bib393","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.fitote.2017.10.015","article-title":"\u03b2-elemene attenuates macrophage activation and proinflammatory factor production via crosstalk with Wnt\/\u03b2-catenin signaling pathway","volume":"124","author":"Fang","year":"2018","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib394","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbrc.2017.06.071","article-title":"\u03b2-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer","volume":"490","author":"Yu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2026.100134_bib395","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105666","article-title":"Anticancer activities of dietary benzyl isothiocyanate: a comprehensive review","volume":"169","author":"Dinh","year":"2021","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib396","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/jn\/136.11.2728","article-title":"Benzyl isothiocyanate-induced DNA damage causes G2\/M cell cycle arrest and apoptosis in human pancreatic cancer cells","volume":"136","author":"Zhang","year":"2006","journal-title":"J Nutr"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib397","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025799","article-title":"Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-\u03b1\/VEGF\/Rho-GTPases: pivotal role of STAT-3","volume":"6","author":"Boreddy","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib398","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jnci\/djn470","article-title":"The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate","volume":"101","author":"Sahu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pharmr.2026.100134_bib399","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116424","article-title":"Benzyl isothiocyanate attenuates activation of the NLRP3 inflammasome in Kupffer cells and improves diet-induced steatohepatitis","volume":"462","author":"Lo","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100134_bib400","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1039\/D1FO00645B","article-title":"Benzyl isothiocyanates modulate inflammation, oxidative stress, and apoptosis via Nrf2\/HO-1 and NF-\u03baB signaling pathways on indomethacin-induced gastric injury in rats","volume":"12","author":"El Badawy","year":"2021","journal-title":"Food Funct"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib401","first-page":"405","article-title":"Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms","volume":"1846","author":"Gupta","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib402","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.981449","article-title":"PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growth","volume":"4","author":"Gupta","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pharmr.2026.100134_bib403","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153493","article-title":"Cancer-preventive effect of phenethyl isothiocyanate through tumor microenvironment regulation in a colorectal cancer stem cell xenograft model","volume":"84","author":"Shin","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib404","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13020-022-00638-z","article-title":"3, 3\u2032-diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells","volume":"17","author":"Sun","year":"2022","journal-title":"Chin Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib405","first-page":"94","article-title":"Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo","volume":"6","author":"Kandala","year":"2012","journal-title":"Drug Discov Ther"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100134_bib406","doi-asserted-by":"crossref","first-page":"25813","DOI":"10.1074\/jbc.M313538200","article-title":"Sulforaphane-induced G2\/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C","volume":"279","author":"Singh","year":"2004","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100134_bib407","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3390\/nu15153405","article-title":"Sulforaphane reduces the chronic inflammatory immune response of human dendritic cells","volume":"15","author":"Fernandez-Prades","year":"2023","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib408","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/09637486.2018.1439901","article-title":"Broccoli and human health: immunomodulatory effect of sulforaphane in a model of colon cancer","volume":"69","author":"Bessler","year":"2018","journal-title":"Int J Food Sci Nutr"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib409","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1158\/0008-5472.CAN-03-2296","article-title":"A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation","volume":"64","author":"Miyoshi","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib410","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1158\/1535-7163.MCT-06-0396","article-title":"Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak","volume":"5","author":"Xiao","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib411","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/carcin\/bgh179","article-title":"Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells","volume":"25","author":"Srivastava","year":"2004","journal-title":"Carcinogenesis"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100134_bib412","doi-asserted-by":"crossref","first-page":"30151","DOI":"10.1074\/jbc.M802529200","article-title":"Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells","volume":"283","author":"Xiao","year":"2008","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib413","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032597","article-title":"Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib414","article-title":"Benzyl isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes","volume":"7","author":"Xie","year":"2017","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100134_bib415","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/foods13132078","article-title":"Benzyl isothiocyanate and resveratrol synergistically alleviate dextran sulfate sodium-induced colitis in mice","volume":"13","author":"Liu","year":"2024","journal-title":"Foods"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib416","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00109-009-0532-6","article-title":"Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin","volume":"87","author":"Lee","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib417","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1223158","article-title":"A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E2","volume":"10","author":"Herz","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.pharmr.2026.100134_bib418","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154524","article-title":"Targeting cancer stem cells and signalling pathways through phytochemicals: a promising approach against colorectal cancer","volume":"108","author":"Liao","year":"2023","journal-title":"Phytomedicine"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100134_bib419","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.3390\/cancers16213699","article-title":"Deciphering CD59: unveiling its role in immune microenvironment and prognostic significance","volume":"16","author":"Patel","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib420","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8856326","article-title":"Ze-Qi-tang formula induces granulocytic myeloid-derived suppressor cell apoptosis via STAT3\/S100A9\/Bcl-2\/Caspase-3 signaling to prolong the survival of mice with orthotopic lung cancer","volume":"2021","author":"Xu","year":"2021","journal-title":"Mediators Inflam"},{"key":"10.1016\/j.pharmr.2026.100134_bib421","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2016.06.018","article-title":"3, 3\u2032-diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy","volume":"115","author":"Ye","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100134_bib422","doi-asserted-by":"crossref","first-page":"28745","DOI":"10.1074\/jbc.M112.351379","article-title":"Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo","volume":"287","author":"Kandala","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib423","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.111.188706","article-title":"Blocking epidermal growth factor receptor activation by 3, 3\u2032-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo","volume":"341","author":"Kandala","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib424","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/mol.110.063750","article-title":"Activation of checkpoint kinase 2 by 3, 3\u2032-diindolylmethane is required for causing G2\/M cell cycle arrest in human ovarian cancer cells","volume":"78","author":"Kandala","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib425","doi-asserted-by":"crossref","first-page":"435","DOI":"10.18632\/oncotarget.483","article-title":"Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK","volume":"3","author":"Kandala","year":"2012","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100134_bib426","first-page":"6120","article-title":"Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines","volume":"61","author":"Bonnesen","year":"2001","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib427","first-page":"1426","article-title":"Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells","volume":"60","author":"Gamet-Payrastre","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib428","first-page":"631","article-title":"Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells","volume":"20","author":"Chiao","year":"2002","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib429","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/carcin\/23.4.581","article-title":"Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane","volume":"23","author":"Fimognari","year":"2002","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/carcin\/bgg178","article-title":"Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo","volume":"25","author":"Singh","year":"2004","journal-title":"Carcinogenesis"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100134_bib431","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1074\/jbc.M412443200","article-title":"Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species","volume":"280","author":"Singh","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib432","article-title":"Anti-cancer effect of sulforaphane in human pancreatic cancer cells Mia PaCa-2","volume":"7","author":"Park","year":"2024","journal-title":"Cancer Rep"},{"key":"10.1016\/j.pharmr.2026.100134_bib433","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sajb.2022.09.031","article-title":"Withania somnifera deploys immunomodulation and exerts anticancer effects on lung adenocarcinoma cells","volume":"151","author":"Sajida","year":"2022","journal-title":"S Afr J Bot"},{"key":"10.1016\/j.pharmr.2026.100134_bib434","doi-asserted-by":"crossref","DOI":"10.12775\/QS.2024.32.56016","article-title":"Ashwagandha (Withania somnifera) in Cancer Therapy: anticancer Activities and Their Mechanisms","volume":"32","author":"Piecuch","year":"2024","journal-title":"Qual Sport"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib435","first-page":"1245","article-title":"Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway","volume":"19","author":"Ren","year":"2016","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib436","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14715\/cmb\/2019.65.4.13","article-title":"Ginkgetin inhibits proliferation of HeLa cells via activation of p38\/NF-\u00ce\u00b0B pathway","volume":"65","author":"Cheng","year":"2019","journal-title":"Cell Mol Biol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100134_bib437","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.3390\/molecules24224062","article-title":"Immune checkpoint PD-1\/PD-L1 CTLA-4\/CD80 are blocked by Rhus verniciflua Stokes and its active compounds","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib438","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(00)00290-4","article-title":"Ginkgo biloba: a living fossil","volume":"108","author":"Jacobs","year":"2000","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib439","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1472-8206.2003.00156.x","article-title":"Ginkgo biloba extracts and cancer: a research area in its infancy","volume":"17","author":"DeFeudis","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib440","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biopha.2017.09.077","article-title":"Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway","volume":"96","author":"Cao","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib441","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s42003-021-01801-2","article-title":"Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens","volume":"4","author":"Darrigrand","year":"2021","journal-title":"Commun Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib442","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/molecules25112540","article-title":"Ginkgo biloba extract protects against methotrexate-induced hepatotoxicity: a computational and pharmacological approach","volume":"25","author":"Al Kury","year":"2020","journal-title":"Molecules"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100134_bib443","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jep.2003.10.016","article-title":"Immunomodulatory and antitumor activity of Piper longum Linn. and piperine","volume":"90","author":"Sunila","year":"2004","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib444","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bcp.2006.05.003","article-title":"Modulation of cadmium induced alterations in murine thymocytes by piperine: oxidative stress, apoptosis, phenotyping and blastogenesis","volume":"72","author":"Pathak","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib445","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43088-022-00196-1","article-title":"Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials","volume":"11","author":"Tripathi","year":"2022","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"issue":"27","key":"10.1016\/j.pharmr.2026.100134_bib446","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1021\/acs.jafc.3c01667","article-title":"Alkaloids from Piper longum exhibit anti-inflammatory activity and synergistic effects with chemotherapeutic agents against cervical cancer cells","volume":"71","author":"Wan","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharmr.2026.100134_bib447","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.772418","article-title":"Anticancer applications and pharmacological properties of piperidine and piperine: a comprehensive review on molecular mechanisms and therapeutic perspectives","volume":"12","author":"Mitra","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib448","doi-asserted-by":"crossref","first-page":"112","DOI":"10.54307\/2025.NWMJ.142","article-title":"Characteristics of the biological activities of the piperidine complex: an anticancer and antioxidant investigation","volume":"5","author":"Sabanc\u0131lar","year":"2025","journal-title":"Northwestern Med J"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib449","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10408399109527536","article-title":"Capsicum\u2014production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences","volume":"29","author":"Govindarajan","year":"1991","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib450","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/ars.2011.4369","article-title":"Apoptosis signal-regulating kinase 1\u2013thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis","volume":"17","author":"Pramanik","year":"2012","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib451","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10495-008-0278-6","article-title":"In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway","volume":"13","author":"Zhang","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmr.2026.100134_bib452","series-title":"Role of Capsaicin in Oxidative Stress and Cancer","first-page":"149","article-title":"Oxidative stress by capsaicin in cancer","author":"Pramanik","year":"2013"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib453","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s10495-014-1007-y","article-title":"Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway","volume":"19","author":"Lau","year":"2014","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib454","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1196\/annals.1397.053","article-title":"Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells","volume":"1095","author":"Kim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib455","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jmf.2004.7.267","article-title":"Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor \u03b3 in HT-29 human colon cancer cells","volume":"7","author":"Kim","year":"2004","journal-title":"J Med Food"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib456","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3892\/mmr.2013.1849","article-title":"Capsaicin induces apoptosis and modulates MAPK signaling in human gastric cancer cells","volume":"9","author":"Park","year":"2014","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib457","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(00)00608-X","article-title":"Induction of apoptosis by capsaicin in A172 human glioblastoma cells","volume":"161","author":"Lee","year":"2000","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib458","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jcpt.13039","article-title":"Application of capsaicin as a potential new therapeutic drug in human cancers","volume":"45","author":"Zhang","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pharmr.2026.100134_bib459","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.716735","article-title":"Discovery of novel inhibitors from medicinal plants for v-domain ig suppressor of T-cell activation","volume":"8","author":"Muneer","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib460","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12937-016-0167-8","article-title":"Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment","volume":"15","author":"Leischner","year":"2016","journal-title":"Nutr J"},{"key":"10.1016\/j.pharmr.2026.100134_bib461","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2019.00051","article-title":"Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity","volume":"10","author":"Hosseinzade","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib462","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-4889(02)00328-2","article-title":"The flavonoid, quercetin, differentially regulates Th-1 (IFN\u03b3) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells","volume":"1593","author":"Nair","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib463","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000078498","article-title":"Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by ActivatedHuman basophils","volume":"134","author":"Hirano","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pharmr.2026.100134_bib464","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fphar.2020.00291","article-title":"Luteolin attenuates allergic nasal inflammation via inhibition of interleukin-4 in an allergic rhinitis mouse model and peripheral blood from human subjects with allergic rhinitis","volume":"11","author":"Liang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib465","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib466","doi-asserted-by":"crossref","first-page":"821","DOI":"10.17576\/jsm-2021-5003-22","article-title":"Effects of apigenin, luteolin, and quercetin on the Natural Killer (NK-92) cells proliferation: a potential role as immunomodulator","volume":"50","author":"Aung","year":"2021","journal-title":"Sains Malays"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib467","first-page":"121","article-title":"Immunomodulatory effects of apigenin, luteolin, and quercetin through natural killer cell cytokine secretion","volume":"12","author":"Oo","year":"2022","journal-title":"J Appl Pharm Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib468","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.ymthe.2018.06.016","article-title":"Combination of Asiatic acid and naringenin modulates NK cell anti-cancer immunity by rebalancing Smad3\/Smad7 signaling","volume":"26","author":"Lian","year":"2018","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib469","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1210\/en.2008-0857","article-title":"Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells","volume":"149","author":"Jiang","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib470","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11481-020-09933-8","article-title":"Apigenin modulates dendritic cell activities and curbs inflammation via RelB inhibition in the context of neuroinflammatory diseases","volume":"16","author":"Ginwala","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib471","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700031","article-title":"Quercetin protects against atherosclerosis by inhibiting dendritic cell activation","volume":"61","author":"Lin","year":"2017","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib472","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbrc.2003.11.108","article-title":"Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-\u03baB","volume":"313","author":"Ahn","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2026.100134_bib473","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.intimp.2017.12.014","article-title":"Isorhamnetin, the active constituent of a Chinese herb Hippophae rhamnoides L, is a potent suppressor of dendritic-cell maturation and trafficking","volume":"55","author":"Shi","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib474","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3480569","article-title":"Induction of endoplasmic reticulum stress pathway by green tea epigallocatechin-3-gallate (EGCG) in colorectal cancer cells: activation of PERK\/p-eIF2 \u03b1\/ATF4 and IRE1 \u03b1","volume":"2019","author":"Md Nesran","year":"2019","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib475","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4149\/neo_2017_410","article-title":"Epigallocatechin gallate inhibits the growth of salivary adenoid cystic carcinoma cells via the EGFR\/Erk signal transduction pathway and the mitochondria apoptosis pathway","volume":"64","author":"Weng","year":"2017","journal-title":"Neoplasma"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib476","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cancers11101496","article-title":"Targeting glycolysis with epigallocatechin-3-gallate enhances the efficacy of chemotherapeutics in pancreatic cancer cells and xenografts","volume":"11","author":"Wei","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib477","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/cancers12040951","article-title":"EGCG mediated targeting of deregulated signaling pathways and non-coding RNAs in different cancers: focus on JAK\/STAT, Wnt\/\u03b2-catenin, TGF\/SMAD, NOTCH, SHH\/GLI, and TRAIL mediated signaling pathways","volume":"12","author":"Farooqi","year":"2020","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100134_bib478","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1089\/ars.2017.7086","article-title":"Differential impact of flavonoids on redox modulation, bioenergetics, and cell signaling in normal and tumor cells: a comprehensive review","volume":"29","author":"Kerimi","year":"2018","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib479","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100134_bib480","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmr.2026.100134_bib481","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111489","article-title":"Flavonoids and their role in oxidative stress, inflammation, and human diseases","volume":"413","author":"Jomova","year":"2025","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharmr.2026.100134_bib482","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107457","article-title":"Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: exploring a novel mode of action","volume":"209","author":"Sitarek","year":"2024","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib483","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/antiox13080922","article-title":"Flavonoids: antioxidant powerhouses and their role in nanomedicine","volume":"13","author":"Zahra","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmr.2026.100134_bib484","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2019.06.001","article-title":"Modulation of regulatory T cells by natural products in cancer","volume":"459","author":"Bahrami","year":"2019","journal-title":"Cancer Lett"},{"issue":"suppl","key":"10.1016\/j.pharmr.2026.100134_bib485","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","article-title":"Cancer prevention and therapy through the modulation of the tumor microenvironment","volume":"35","author":"Casey","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100134_bib486","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.3390\/ijms25158375","article-title":"Natural alkaloids in cancer therapy: berberine, sanguinarine and chelerythrine against colorectal and gastric cancer","volume":"25","author":"Duda-Madej","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib487","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/medicines6020051","article-title":"Camptothecin induces PD-L1 and immunomodulatory cytokines in colon cancer cells","volume":"6","author":"Bedi","year":"2019","journal-title":"Medicines"},{"key":"10.1016\/j.pharmr.2026.100134_bib488","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153904","article-title":"Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages","volume":"99","author":"Shah","year":"2022","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib489","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"J Immunol"},{"issue":"suppl 1","key":"10.1016\/j.pharmr.2026.100134_bib490","doi-asserted-by":"crossref","first-page":"653","DOI":"10.15171\/apb.2015.089","article-title":"Modulation of cytokine production and transcription factors activities in human Jurkat T cells by thymol and carvacrol. J Advanced pharmaceutical bulletin","volume":"5","author":"Gholijani","year":"2015","journal-title":"Adv Pharm Bull"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib491","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1476-5381.2010.00874.x","article-title":"Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway","volume":"161","author":"Li","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100134_bib492","doi-asserted-by":"crossref","first-page":"52517","DOI":"10.18632\/oncotarget.9593","article-title":"Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence","volume":"7","author":"Kotecha","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib493","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/cancers14051100","article-title":"Therapeutic potential of certain terpenoids as anticancer agents: a scoping review","volume":"14","author":"Kamran","year":"2022","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100134_bib494","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.3390\/nu16234143","article-title":"Polyphenols as immunomodulators and epigenetic modulators: an analysis of their role in the treatment and prevention of breast cancer","volume":"16","author":"Eren","year":"2024","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib495","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1570161115666170713094319","article-title":"Potential role of natural compounds as anti-angiogenic agents in cancer","volume":"15","author":"Shanmugam","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100134_bib496","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102182","article-title":"The anti-cancer effectiveness of some heterocyclic compounds containing sulfur atom","volume":"15","author":"Hamad","year":"2025","journal-title":"Results Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib497","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib498","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/molecules27020349","article-title":"Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents","volume":"27","author":"Najmi","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib499","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-14-0160","article-title":"Toxic phytochemicals and their potential risks for human cancer","volume":"8","author":"Bode","year":"2015","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib500","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1037861","article-title":"Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: a randomized, double-blind, and placebo-controlled trial","volume":"9","author":"Karimi","year":"2022","journal-title":"Front Nutr"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100134_bib501","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100134_bib502","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1002\/ptr.7294","article-title":"A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients","volume":"35","author":"Hassaniazad","year":"2021","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib503","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-021-01438-1","article-title":"Potential of anthocyanin as an anti-inflammatory agent: a human clinical trial on type 2 diabetic, diabetic at-risk and healthy adults","volume":"70","author":"Nikbakht","year":"2021","journal-title":"Inflamm Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib504","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.numecd.2012.06.005","article-title":"Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial","volume":"23","author":"Zhu","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.pharmr.2026.100134_bib505","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110745","article-title":"A dose-response evaluation of purified anthocyanins on inflammatory and oxidative biomarkers and metabolic risk factors in healthy young adults: a randomized controlled trial","volume":"74","author":"Guo","year":"2020","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100134_bib506","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2468-1253(19)30409-1","article-title":"Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib507","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1940-6207.CAPR-19-0258","article-title":"A phase I trial of berberine in Chinese with ulcerative colitis","volume":"13","author":"Xu","year":"2020","journal-title":"Cancer Prev Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100134_bib508","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamadermatol.2022.1736","article-title":"Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy: a double-blind, placebo-controlled, phase 2 randomized clinical trial","volume":"158","author":"Zhao","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100134_bib509","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10067-018-4080-8","article-title":"Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study","volume":"37","author":"Khojah","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib510","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jgr.2024.05.007","article-title":"Enhanced immunity effect of Korean Red ginseng capsule: a randomized, double-blind and placebo-controlled clinical trial","volume":"48","author":"Yang","year":"2024","journal-title":"J Ginseng Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100134_bib511","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1142\/S0192415X02000661","article-title":"Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer","volume":"30","author":"Suh","year":"2002","journal-title":"Am J Chin Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100134_bib512","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000509829","article-title":"Can use of silymarin improve inflammatory status in patients with \u03b2-thalassemia major? a crossover, randomized controlled trial","volume":"28","author":"Darvishi-Khezri","year":"2021","journal-title":"Complement Med Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib513","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22073-8","article-title":"A randomized trial assessing the efficacy of silymarin on endometrioma-related manifestations","volume":"12","author":"Mirzaei","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib514","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ptr.6046","article-title":"Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial","volume":"32","author":"Homayouni","year":"2018","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100134_bib515","first-page":"847","article-title":"The effects of lycopene on modulating oxidative stress and liver enzymes levels in metabolic syndrome patients: a randomised clinical trial","volume":"25","author":"Mirahmadi","year":"2023","journal-title":"Cell J"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib516","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1158\/1940-6207.CAPR-15-0380","article-title":"Clinical trial of 2-phenethyl isothiocyanate as an inhibitor of metabolic activation of a tobacco-specific lung carcinogen in cigarette smokers","volume":"9","author":"Yuan","year":"2016","journal-title":"Cancer Prev Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib517","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-017-4292-7","article-title":"A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen","volume":"165","author":"Thomson","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100134_bib518","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/1940-6207.CAPR-24-0386","article-title":"Randomized phase II clinical trial of sulforaphane in former smokers at high risk for lung cancer","volume":"18","author":"Yuan","year":"2025","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.pharmr.2026.100134_bib519","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejogrb.2022.09.021","article-title":"Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: a randomized clinical trial","volume":"278","author":"Bahrami","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib520","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13063-025-08916-5","article-title":"Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial","volume":"26","author":"Alikiaii","year":"2025","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100134_bib521","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12937-023-00905-1","article-title":"The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: a randomized controlled trial","volume":"22","author":"Boshagh","year":"2023","journal-title":"Nutr J"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100134_bib522","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.3390\/jcm10163644","article-title":"Immunomodulatory effect of Withania somnifera (Ashwagandha) extract-A randomized, double-blind, placebo controlled trial with an open label extension on healthy participants","volume":"10","author":"Tharakan","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.pharmr.2026.100134_bib523","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v68.10297","article-title":"A standardized combination of Terminalia chebula and Withania somnifera extracts enhances immune function in adults: a pilot randomized, double-blind, placebo-controlled clinical study","volume":"68","author":"Sadhupati","year":"2024","journal-title":"Food Nutr Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100134_bib524","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/03639045.2025.2483425","article-title":"Nanoparticle-based delivery systems for phytochemicals in cancer therapy: molecular mechanisms, clinical evidence, and emerging trends","volume":"51","author":"Mostafa","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharmr.2026.100134_bib525","series-title":"Medicinal Plants and their Bioactives in Human Diseases","first-page":"207","article-title":"Safety, dosage, and regulatory aspects in the use of phytochemicals","author":"Karthikeyan","year":"2025"},{"key":"10.1016\/j.pharmr.2026.100134_bib526","series-title":"Medicinal Plants and their Bioactives in Human Diseases","first-page":"331","article-title":"Safety, dosage, and regulatory aspects in the use of phytochemicals against cancer","author":"Samal","year":"2025"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100134_bib527","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"issue":"7637","key":"10.1016\/j.pharmr.2026.100134_bib528","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:46:04Z","timestamp":1779446764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":529,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0031699726000220"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100134","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory and anticancer effects of phytochemicals: A comprehensive analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100134"}}